These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25668688)

  • 1. Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series.
    Gu W; Zhu Y; Wang H; Zhang H; Shi G; Liu X; Ye D
    PLoS One; 2015; 10(2):e0118022. PubMed ID: 25668688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study.
    Wang J; Dong P; Qu Y; Xu W; Zhou Z; Ning K; Peng Y; Xiong L; Li Z; Zou X; Liu Z; Li M; He Z; Luo J; Tian X; Zhang H; Guo S; Han H; Zhou F; Yin S; Ye D; Yu C; Zhang Z
    Eur Radiol; 2023 May; 33(5):3232-3242. PubMed ID: 36538073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
    Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
    Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy.
    Lee HW; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Int J Urol; 2015 May; 22(5):455-61. PubMed ID: 25631365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma.
    Park YH; Lee JK; Kim KM; Kook HR; Lee H; Kim KB; Lee S; Byun SS; Lee SE
    J Urol; 2014 Oct; 192(4):1043-9. PubMed ID: 24704011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Body Composition Parameters Measured by Computed Tomography with Cancer Stage, Prognosis, and Survival in Patients with Renal Cell Carcinoma.
    Gur Ozcan SG; Barali D; Erkan A
    Curr Med Imaging; 2024; 20(1):e15734056301569. PubMed ID: 38544394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma.
    Bradshaw PT; Olsson LT; Sanchez A; Knezevic A; Akin O; Scott JM; Hakimi AA; Russo P; Caan BJ; Mourtzakis M; Furberg H
    Cancer Epidemiol Biomarkers Prev; 2024 Oct; 33(10):1375-1382. PubMed ID: 39073365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
    Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
    Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
    Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
    Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.
    Kaneko G; Miyajima A; Yuge K; Yazawa S; Mizuno R; Kikuchi E; Jinzaki M; Oya M
    Jpn J Clin Oncol; 2015 Feb; 45(2):210-6. PubMed ID: 25420691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy.
    Mizuno R; Miyajima A; Hibi T; Masuda A; Shinojima T; Kikuchi E; Jinzaki M; Oya M
    Med Oncol; 2017 Apr; 34(4):47. PubMed ID: 28213730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
    Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
    Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade.
    Hu Z; Wu J; Lai S; Xu Y; Zhan J; Li R; Liu X; Wang N; Wei X; Jiang X; Yang R
    Eur Radiol; 2020 Jul; 30(7):3977-3986. PubMed ID: 32144457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.
    Kim SH; Kim JK; Park EY; Joo J; Lee KH; Seo HK; Joung JY; Chung J
    PLoS One; 2019; 14(2):e0211105. PubMed ID: 30785902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma.
    Du Y; Yang W; Liu H; Qin C; Tang X; Xu T
    Clin Genitourin Cancer; 2022 Feb; 20(1):e75-e80. PubMed ID: 34802967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels.
    Greco F; Quarta LG; Grasso RF; Beomonte Zobel B; Mallio CA
    Br J Radiol; 2020 Aug; 93(1112):20200334. PubMed ID: 32516557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
    Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
    Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.
    Ishihara H; Nishimura K; Ikeda T; Fukuda H; Yoshida K; Iizuka J; Kondo T; Takagi T
    Urol Oncol; 2024 Sep; 42(9):291.e27-291.e37. PubMed ID: 38653590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
    Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
    Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.